The retrade is a method, not an accident. Price is agreed before confirmatory diligence, so the buyer’s real information arrives only after your other buyers are gone. The defenses are written into the letter of intent, not argued two weeks before closing: stated assumptions, objective standards, milestone-conditioned exclusivity, a cost underwrite, and a second buyer kept warm.
Why does a price cut show up two weeks before closing?
Sequence explains the retrade. The letter of intent fixes price on your numbers. Exclusivity removes the other buyers. Confirmatory diligence then hands the buyer information you can no longer re-shop. The buyer’s leverage peaks at the exact moment your alternatives disappear. That timing is structural, not coincidental.
Which letter of intent clauses set up a retrade before diligence starts?
Five provisions in a letter of intent do the setup work: an assumptions recital, buyer-satisfaction conditions, a provisional price pending an accountant’s review, an open stock-versus-asset structure, and no stated working capital target. Each one quietly converts a later diligence finding into a documented reason to pay you less.
| The setup clause | What it actually does | What to ask for instead |
|---|---|---|
| An assumptions recital: “price assumes adjusted EBITDA of $X and the add-backs on Schedule 1” | Every assumption becomes a tripwire. Any one disproved is a documented basis to cut, even where the variance is immaterial. | Variances handled by representations, escrow, or indemnity, not price. If price must move: a floor, a cap, a mutual right to walk. |
| Conditions “satisfactory to buyer in its sole discretion” | Close to unreviewable. Courts read the implied covenant of good faith narrowly and rarely rescue a seller from language it signed. | “Reasonable satisfaction,” plus what failure means. Objective standards create arguments you can win. |
| Price “subject to completion of a quality of earnings review,” with no floor or cap | Leaves price open on the buyer’s side and fixed on yours. | Adjustment limited to quantified recast errors, with a floor, a cap, and your right to terminate above it. |
| Structure left open between a stock sale and an asset sale | A late switch moves tax burden and retained liability onto you. A price cut in another currency. | Name the structure and the allocation method. Say who bears the difference if either changes. |
| No stated working capital target | The target gets set after exclusivity, on the buyer’s spreadsheet. | A stated target, method, and reference period consistent with past practice. |
Working capital is worth a note. The American Bar Association’s deal points study of private target acquisitions reports purchase price adjustments in most agreements reviewed, working capital as the dominant metric, and the buyer preparing the first calculation almost every time. Those deals are far larger than yours. Read it as directional, not as what to expect at your size, where some agreements carry a post-closing true-up and others none.
Data: ABA Business Law Section, Private Target Mergers and Acquisitions Deal Points Study, 2025 edition (published December 2025).
How does a buyer turn a diligence finding into a price cut instead of an indemnity?
Characterization is the whole move. A diligence finding has three possible homes: a representation with indemnity behind it, an escrow holdback, or a permanent price reduction. Buyers argue for the third. A dollar off the price is certain and immediate. An indemnity pays only if the problem materializes.
Take the environmental example. A Phase I assessment flags a recognized environmental condition and recommends further investigation. The buyer’s counsel produces a remediation range and proposes the high end as a dollar-for-dollar cut. A liability screen just became a valuation input.
That process serves a federal purpose, and the purpose is the buyer’s. All appropriate inquiries is one condition of the bona fide prospective purchaser and innocent landowner defenses to federal cleanup liability, not the whole test; the buyer must also meet the statute’s continuing obligations after closing. Nothing in it converts an estimate into a price. And it does nothing for you: a former owner or operator can remain a responsible party anyway.
Law: 42 U.S.C. 9601(35), 9601(40), 9607(r); 40 C.F.R. Part 312; EPA final rule published December 15, 2022, effective February 13, 2023, recognizing ASTM E1527-21.
The accounting version works the same way. A provider reclassifies an add-back you treated as nonrecurring, adjusted earnings fall, and the reduction is multiplied. Ask for the schedule and the arithmetic, item by item. Contingent findings belong in escrow. Only findings that permanently change the earnings base belong in price.
An estimate with a range in it is not a price. It is an escrow with a number in it.
Can a buyer use a material adverse effect claim to force a lower price?
A material adverse effect assertion is a threat that courts rarely validate. Your own agreement’s definition controls, but Delaware reads these clauses narrowly: the event must be unknown and must threaten the target’s overall earnings potential in a durationally significant way. Buyers assert it by phone, and rarely in a termination notice.
Delaware is the reference point for a limited reason: your agreement will probably be governed by your own state’s law, but Delaware’s opinions are the ones the buyer’s counsel has read. Chancery called the clause a backstop against unknown events, held a short-term earnings decline insufficient, and ordered the buyer to close.
Case: In re IBP, Inc. Shareholders Litigation, 789 A.2d 14 (Del. Ch. 2001).
The bar was confirmed later. An earnings decline must be expected to persist significantly into the future. That buyer had also knowingly breached its own obligations, which took its exposure outside the negotiated damages cap.
Case: Hexion Specialty Chemicals, Inc. v. Huntsman Corp., 965 A.2d 715 (Del. Ch. 2008).
Chancery did find a material adverse effect in 2018, and the Delaware Supreme Court affirmed. The facts were extreme: a collapse in performance plus regulatory representations untrue in a manner tied to the company’s dealings with a federal regulator. That is where the doctrine lives.
Case: Akorn, Inc. v. Fresenius Kabi AG (Del. Ch. Oct. 1, 2018), aff’d, 198 A.3d 724 (Del. Dec. 7, 2018).
Read those cases for the standard, not the remedy. All involved public companies that could fund a year of litigation, and forcing a reluctant buyer to close usually costs you more than the concession demanded. So test the assertion. A buyer who believes a material adverse effect occurred sends a notice; a buyer who wants a discount says the words and keeps scheduling the closing. Ask for it in writing, naming the event and the provision.
A buyer who cannot name the finding is not repricing your business. He is pricing your exhaustion.
Can your own performance during the process justify a real price cut?
Yes, and this is the one repricing a buyer earns honestly. Performance that slips between the management presentation and closing is a fact, not a tactic. A missed quarter against your own projections, a lost top-five customer, a key manager who resigns: each is a real valuation event.
After signing, the ordinary-course covenant adds a second exposure. A seller of hotel properties shut operations down in response to the pandemic. The court accepted the closures as reasonable and consistent with industry practice, then held the seller had still breached its unqualified promise to operate consistent with past practice, and that the buyer could terminate. The same opinion found no material adverse effect, because the definition carved out calamities. That seller lost on its own covenant.
Case: AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC (Del. Ch. Nov. 30, 2020), aff’d, 268 A.3d 198 (Del. 2021).
Consequence. Between signing and closing, get written consent for anything outside past practice. Reasonableness did not save that seller. Consent would have.
Which defenses against a retrade actually work?
Five defenses do real work, and every one of them is installed before exclusivity begins: sell-side diligence, early disclosure into a competitive field, milestone-conditioned exclusivity, a cost underwrite triggered by a material change in terms, and a live second buyer. Once exclusivity begins, your remaining tools are the calendar and your credibility.
- Sell-side quality of earnings before going to market. Your accountant finds the add-back problems while you still have every buyer, and you price the correction once, yourself.
- Known problems into the data room while several buyers are live. In a competitive field, a disclosure is a discount someone else may decline to take. In exclusivity, it is a reduction with no market test.
- Milestone-conditioned exclusivity. A short window, extended only if the buyer delivers stated items by stated dates: a diligence request list, a signed engagement with its earnings reviewer, a lender term sheet, a first draft agreement. Draft the lapse as automatic, no cure period, inside the binding provisions.
- A signing date at the letter of intent price. Past that date, exclusivity lapses. A buyer with financing meets the date. A buyer testing your fatigue negotiates the date instead. That is the diagnosis.
- A cost underwrite on a material change in terms. If the buyer proposes a price reduction or an adverse structure change and you terminate, it reimburses your documented out-of-pocket costs up to a stated cap. Buyers at this size often refuse. Ask anyway, and read a refusal as information.
- A second buyer kept warm. The only defense that prices itself. Keep the window short so the runner-up is still available when it expires, and keep your conduct inside the no-shop. That paragraph binds you even when the rest of the letter does not.
One point on the binding paragraph. Delaware has enforced an express obligation to negotiate in good faith in accordance with a signed term sheet, and awarded expectation damages where the parties would have reached agreement but for one side’s bad faith. Note the qualification: that duty was express. A letter of intent saying it is non-binding and creates no duty to negotiate is generally enforced as written. What matters is which provisions you made binding.
Case: SIGA Technologies, Inc. v. PharmAthene, Inc., 67 A.3d 330 (Del. 2013), damages affirmed, 132 A.3d 1108 (Del. 2015).
Does the buyer’s financing change the retrade math?
Lender-driven repricing is a different animal from a tactical retrade, and you should learn to tell them apart. If your buyer is using an SBA 7(a) loan, an independent business valuation and the agency’s equity rules can genuinely cap what that buyer can pay. A valuation below your price is a finding. A committee’s mood is not.
Under the SBA operating procedures in force as of August 2026, a complete change-of-ownership loan requires an equity injection of at least ten percent of total project costs from the buyer. A seller note can cover no more than half of that, and only on full standby, meaning no principal and no interest payments for the life of the SBA loan. So “we will bridge the gap with a seller note” has hard limits.
Valuation is a version question. Under the procedures governing applications now, the lender may use an internal valuation below a stated intangible-value threshold, $250,000 as of August 2026, and must order an independent appraisal above it. The incoming version requires an independent valuation on every change of ownership and adds financial due diligence, including a quality of earnings review above a stated purchase price.
Rule: SBA SOP 50 10 8, effective June 1, 2025, governs applications through September 30, 2026. SOP 50 10 8.1, announced August 14, 2026, applies to loan numbers assigned on or after October 1, 2026. Confirm which version your buyer’s lender applies.
So ask for the lender term sheet and the valuation timing before granting exclusivity. If your buyer is bank-financed, an outside look at your earnings is coming either way. A financing-driven price problem found in month four was knowable in week two.
Does the stock-versus-asset question belong in the letter of intent?
Yes, because structure is price. As of August 2026, an asset acquisition requires both buyer and seller to report the allocation of consideration among the transferred assets on IRS Form 8594, each filed with that party’s return for the tax year that includes the sale date. Allocation drives what each side keeps.
If your company is an S corporation, there is a second pressure point. As of August 2026, a Section 338(h)(10) deemed asset sale election is made jointly, requires a corporate buyer acquiring at least eighty percent of your stock by vote and value, and needs consent from every target shareholder, including those not selling. It is filed on Form 8023, due the fifteenth day of the ninth month beginning after the month of the acquisition date. Many buyers at this size are limited liability companies, which cannot make that election at all; those deals use a Section 336(e) election or a pre-sale reorganization. Raised after exclusivity, this is a request to change your tax outcome when you have the least room to refuse.
Law: 26 U.S.C. 1060, Treas. Reg. 1.1060-1, IRS Form 8594; 26 U.S.C. 338(h)(10), Treas. Reg. 1.338(h)(10)-1, IRS Form 8023; 26 U.S.C. 336(e), Treas. Reg. 1.336-1.
Do all of it before any letter of intent is signed. The price cut two weeks before closing is not persuasion. It is arithmetic about your remaining options. Change it while you can.
Keep reading
The Buyer’s LibraryThe seller runs the business until you fund.The Seller’s LibraryEverything you do not settle in the letter of intent, you concede after you sign itThe Seller’s LibraryExclusivity is the one term you give away for free
Have a lawyer read it before you sign.
A sale is decided in a handful of documents you sign exactly once — the letter of intent, the working capital definition, the indemnity. There is no rush. When you want those read properly, we are here.
Before founding Prencipe International, Joe practiced at the top law firms in the world, including Freshfields Bruckhaus Deringer, Baker McKenzie, Morgan Lewis & Bockius, and served at the U.S. Securities and Exchange Commission. He has spent his career on high-stakes disputes and transactions for businesses that cannot afford to lose. He represents owners selling the company they spent a career building -- reading the letter of intent before it is signed, and the purchase agreement while there is still room to change it.
LinkedIn →
